# Awsaj (Lycium shawii)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/awsaj-lycium-shawii
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-05
**Evidence Score:** 1 / 10
**Category:** Middle Eastern
**Also Known As:** Lycium shawii Roem. & Schult., Awsaj, Gargad, Shaw's boxthorn, Arabian desert wolfberry

## Overview

Lycium shawii contains nine characterized phenolic bioactives—including quercetin glycosides, gallic acid, rutin, and hydroxycinnamic acids—that contribute to [antioxidant](/ingredients/condition/antioxidant), [anti-inflammatory](/ingredients/condition/inflammation), and [antimicrobial](/ingredients/condition/immune-support) activity measured in vitro. Methanolic extracts exhibited the highest total phenolic content at 26.265 mg GAE/g, and essential-oil fractions produced an IC50 of 4.66 mg/L against MCF-7 breast cancer cells in cell culture, though no human clinical trials have yet confirmed therapeutic efficacy in any indication.

## Health Benefits

- **[Antioxidant Activity](/ingredients/condition/antioxidant)**: The methanolic extract, richest in polyphenols at 26.265 mg GAE/g, scavenges free radicals through the electron-donating capacity of gallic acid, quercetin, and rutin, protecting cells from oxidative damage in vitro.
- **Anti-Diabetic Potential**: Arabian folk medicine historically employs water decoctions of Awsaj to manage [blood glucose](/ingredients/condition/weight-management), a use plausibly linked to quercetin's known inhibition of α-glucosidase and α-amylase enzymes, though direct clinical verification in Lycium shawii is lacking.
- **Antimalarial Activity**: In vitro screening of Lycium shawii extracts has confirmed antimalarial bioactivity, positioning it as a candidate for further investigation against Plasmodium species, consistent with its traditional use in malaria-endemic regions of the Arabian Peninsula.
- **Antibacterial Effects**: Chloroform extract demonstrated the lowest minimum inhibitory concentration (MIC) at 0.03125 mg/mL against tested bacterial strains, suggesting lipophilic constituents—potentially terpenoids or hydrophobic phenolics—disrupt microbial membrane integrity.
- **[Anti-Inflammatory](/ingredients/condition/inflammation) Properties**: Quercetin, rutin, and ferulic acid present in Lycium shawii are established inhibitors of NF-κB signaling and COX enzyme activity in other plant systems; in vitro studies confirm anti-inflammatory bioactivity for this species, though the exact pathway contribution of each compound has not been individually quantified.
- **Cytotoxic / Anticancer Potential**: The essential oil fraction produced an IC50 of 4.66 mg/L against MCF-7 human breast adenocarcinoma cells in cell culture, indicating selective cytotoxicity worthy of further mechanistic investigation; volatile terpenoid constituents are the likely active agents.
- **Broad-Spectrum [Antimicrobial](/ingredients/condition/immune-support) Activity**: Across water, methanol, ethanol, acetone, and chloroform extracts, MIC values ranged from 0.03125 to 0.125 mg/mL, demonstrating polarity-dependent antimicrobial potency that reflects the diverse chemical classes—from hydrophilic phenolics to lipophilic terpenoids—present in the plant.

## Mechanism of Action

The primary antioxidant and [anti-inflammatory](/ingredients/condition/inflammation) mechanisms of Lycium shawii are attributable to its flavonoid and phenolic acid complement: quercetin and its glycosides (quercetin 3-methoxy glucoside, quercetin 3,7-diglucoside, quercetin 3-O-β-glucoside) donate hydrogen atoms to neutralize [reactive oxygen species](/ingredients/condition/antioxidant) and inhibit pro-inflammatory enzymes including cyclooxygenase-2 and lipoxygenase, while gallic acid and 2,3-dihydroxybenzoic acid contribute additional radical-scavenging capacity through their ortho-dihydroxy phenolic groups. Rutin and p-coumaric acid modulate NF-κB nuclear translocation, reducing transcription of downstream cytokines such as TNF-α and IL-6 in inflammatory cell models. The putative anti-diabetic action involves inhibition of carbohydrate-hydrolyzing enzymes (α-glucosidase and α-amylase) by quercetin aglycone and ferulic acid, slowing post-prandial glucose absorption—a mechanism thoroughly characterized in related Lycium species and structurally analogous flavonoids but not yet demonstrated directly for Lycium shawii in enzymatic assay publications. Cytotoxicity against MCF-7 cells attributed to the essential oil likely involves [mitochondrial](/ingredients/condition/energy) membrane disruption and induction of apoptotic cascades by terpenoid volatiles, though intracellular targets have not been molecularly characterized for this species.

## Clinical Summary

No human clinical trials have been conducted on Lycium shawii for any indication, including its primary traditional use as an anti-diabetic agent. The current clinical evidence gap means that all purported health benefits rest on in vitro bioactivity data and ethnopharmacological precedent from Arabian folk medicine. While the identified phytochemicals—particularly quercetin derivatives and gallic acid—have robust independent clinical evidence in other plant contexts, their specific pharmacokinetics, oral bioavailability, and therapeutic doses have not been established for Lycium shawii extracts or formulations. Until well-designed preclinical animal studies and subsequently human trials are completed, confidence in the clinical translation of this plant's bioactivity remains very low.

## Nutritional Profile

Lycium shawii is phytochemically rich relative to its arid-adapted size, with 148 metabolites detected across extracts in metabolomics profiling, of which 45 are classified phytochemicals. Key quantified polyphenols include gallic acid, 2,3-dihydroxybenzoic acid, quercetin aglycone, quercetin 3-methoxy glucoside, quercetin 3,7-diglucoside, quercetin 3-O-β-glucoside, rutin, p-coumaric acid, and ferulic acid; total phenolic content in methanolic extract measures 26.265 ± 0.005 mg GAE/g dry material. The water extract contains predominantly sugar-associated signals (60.12 ± 2.80% by spectroscopic analysis), indicating significant carbohydrate content including polysaccharides that may contribute independently to bioactivity through [immunomodulatory](/ingredients/condition/immune-support) mechanisms common to Lycium genus polysaccharides. Macro- and micronutrient concentrations (protein, fat, minerals, vitamins) have not been formally characterized in the published literature; berries of related Lycium barbarum (goji) are rich in zeaxanthin, betaine, and polysaccharides, suggesting Lycium shawii may share partial nutritional homology, but direct data are absent.

## Dosage & Preparation

- **Traditional Water Decoction**: Aerial parts (leaves, twigs, berries) boiled in water; this aligns with traditional Arabian folk medicine preparation and was specifically evaluated in research to mirror ethnobotanical use; no standardized volume or concentration established.
- **Methanolic Extract (Research Standard)**: Highest polyphenol yield at 26.265 mg GAE/g; used in laboratory bioactivity assays; not a commercially available supplement form; referenced concentration for in vitro [antimicrobial](/ingredients/condition/immune-support) MIC: 0.03125–0.125 mg/mL.
- **Essential Oil**: Steam-distilled from plant material; active against MCF-7 cells at IC50 4.66 mg/L in vitro; no therapeutic dose established for human use.
- **Ethanol / Acetone / Chloroform Extracts**: Evaluated in research settings only; chloroform extract showed the most potent antimicrobial activity (MIC 0.03125 mg/mL) due to enrichment of lipophilic constituents; not suitable for direct human consumption.
- **Standardized Supplement Form**: No commercially standardized extract (e.g., standardized to % quercetin or total polyphenols) is currently available; no clinically validated dose range exists for any indication.
- **Timing Note**: No pharmacokinetic data exist to guide timing recommendations; traditional use suggests decoctions taken at mealtimes for blood sugar management, consistent with the proposed α-glucosidase inhibition mechanism.

## Safety & Drug Interactions

No formal human safety studies, toxicology assessments, or adverse event reports have been published for Lycium shawii in any extract form, and the absence of such data precludes confident safety characterization at any dose. The plant belongs to the Solanaceae family, which includes species containing tropane alkaloids and other potentially toxic secondary metabolites; while no such alkaloids have been specifically identified in Lycium shawii to date, phytochemical screening is incomplete and caution is warranted. Because the plant's quercetin and flavonoid content may inhibit cytochrome P450 enzymes (particularly CYP3A4 and CYP2C9) at high intake levels—a known property of quercetin-rich botanicals—theoretical interactions with anticoagulants (warfarin), immunosuppressants (cyclosporine), and antidiabetic medications (sulfonylureas, metformin) cannot be excluded. Pregnant and lactating women, as well as individuals with autoimmune conditions or those scheduled for surgery, should avoid use until adequate safety data are available; no maximum safe dose has been established for any population.

## Scientific Research

Published evidence for Lycium shawii consists entirely of in vitro phytochemical characterization and bioactivity screening studies; no randomized controlled trials, animal pharmacology studies, or human pharmacokinetic investigations have been indexed in the available peer-reviewed literature as of 2024. A comprehensive metabolomics study identified 148 total metabolites across five solvent extracts (water, methanol, ethanol, acetone, chloroform), with 45 classified as phytochemicals, and quantified total phenolic content across extract types, establishing methanolic extraction as superior for polyphenol recovery. [Antimicrobial](/ingredients/condition/immune-support) MIC testing across these five extracts against bacterial strains, along with cytotoxicity screening of the essential oil against MCF-7 cells (IC50 4.66 mg/L), represent the most quantitatively rigorous data points currently available. The overall evidence base is sparse and pre-clinical, supporting biological plausibility for the plant's traditional uses without providing sufficient data for evidence-based dosing or clinical recommendations.

## Historical & Cultural Context

Lycium shawii, known in Arabic as Awsaj (أوسج) or sometimes Gargad, holds a documented place in Arabian folk medicine across Saudi Arabia, Oman, Yemen, and the broader Levant region, where its decoctions have been used for generations to manage diabetes, fever, and gastrointestinal complaints. The plant is also ethnobotanically significant in Islamic cultural heritage; Gargad is specifically mentioned in prophetic hadith literature as one of the trees of the people of the Dajjal, lending it a spiritual dimension beyond its medicinal applications. Traditional healers prepare the remedy primarily as a hot water infusion or decoction of leaves and twigs, drunk as a tea-like beverage, a practice that modern phytochemical research has validated as an effective extraction method for water-soluble polyphenols including rutin and quercetin glycosides. The plant's resilience in harsh desert environments has also made it symbolically associated with endurance in Bedouin culture, and its berries are occasionally consumed as a minor food source during pastoral travels across the Arabian Peninsula.

## Synergistic Combinations

Lycium shawii's quercetin glycoside content may act synergistically with other α-glucosidase inhibitors such as berberine or cinnamon (Cinnamomum verum) extract, producing additive or potentially supra-additive post-prandial glucose blunting through complementary enzyme-inhibitory mechanisms, though this combination has not been tested for this specific species. The gallic acid and ferulic acid components share [antioxidant](/ingredients/condition/antioxidant) and anti-[inflammatory pathway](/ingredients/condition/inflammation)s with curcumin (Curcuma longa) and green tea catechins (EGCG), suggesting that formulations pairing Lycium shawii with these polyphenols could theoretically enhance NF-κB suppression and redox homeostasis—a rationale consistent with traditional Middle Eastern polyherbalism but unverified experimentally. Vitamin C co-administration may regenerate quercetin radical intermediates back to their active reduced form, enhancing antioxidant cycling and extending the effective duration of quercetin-mediated radical scavenging.

## Frequently Asked Questions

### What is Lycium shawii used for in traditional medicine?

In Arabian folk medicine, Lycium shawii (Awsaj) is primarily used as an anti-diabetic remedy, with water decoctions of the leaves and twigs consumed at mealtimes to help manage blood glucose levels. It is also traditionally applied for fever, gastrointestinal complaints, and general inflammation, reflecting its broad ethnopharmacological role across Saudi Arabia, Oman, and neighboring countries.

### What active compounds are found in Lycium shawii?

Nine key bioactive phenolic compounds have been identified: quercetin, quercetin 3-methoxy glucoside, quercetin 3,7-diglucoside, quercetin 3-O-β-glucoside, rutin, gallic acid, 2,3-dihydroxybenzoic acid, p-coumaric acid, and ferulic acid. A comprehensive metabolomics analysis detected 148 total metabolites across solvent extracts, with the methanolic extract yielding the highest total phenolic content at 26.265 mg gallic acid equivalents per gram.

### Is there clinical trial evidence supporting Lycium shawii for diabetes?

No human clinical trials have been conducted on Lycium shawii for diabetes or any other condition as of 2024; all available evidence is limited to in vitro cell culture and phytochemical studies. The anti-diabetic rationale is biologically plausible—quercetin and ferulic acid are established α-glucosidase inhibitors in other plant systems—but therapeutic doses and clinical efficacy have not been established for this specific species.

### Is Lycium shawii the same as goji berry?

Lycium shawii is a distinct species from the commonly marketed goji berry (Lycium barbarum or Lycium chinense) and is native to the Arabian Peninsula and North Africa rather than China and the Himalayan foothills. While both belong to the Lycium genus (Solanaceae family) and share some phytochemical classes such as flavonoids and polysaccharides, Lycium shawii has its own unique phytochemical profile and has not been commercially developed as a food or supplement product.

### What are the safety concerns with taking Lycium shawii?

No formal human toxicology or safety studies have been published for Lycium shawii, making it impossible to define a safe therapeutic dose at this time. As a Solanaceae family member with quercetin-rich extracts, theoretical risks include cytochrome P450 enzyme inhibition that could interact with anticoagulants, antidiabetic drugs, or immunosuppressants; pregnant and lactating women should avoid use entirely until safety data become available.

### What is the most bioavailable form of Lycium shawii for antioxidant benefits?

Methanolic and water extracts of Lycium shawii demonstrate the highest antioxidant activity, with the methanolic extract containing 26.265 mg GAE/g of polyphenols—significantly richer than other extraction methods. Water decoctions, traditionally used in Arabian folk medicine, provide bioavailable quercetin and rutin that can cross cellular membranes to scavenge free radicals. Standardized extracts preserving these polyphenols may offer more consistent antioxidant potency than whole plant material.

### How does Lycium shawii compare to common goji berry supplements for antioxidant activity?

While both are Lycium species used traditionally for health benefits, Lycium shawii (Awsaj) is botanically distinct and shows substantial polyphenol content (26.265 mg GAE/g in methanolic extracts) that rivals other Lycium species. Lycium shawii's specific profile of gallic acid, quercetin, and rutin provides targeted free-radical scavenging, though direct comparative clinical trials between Lycium shawii and common goji berry varieties are limited. Geographic origin and extraction method significantly affect antioxidant potency in both species.

### Who may benefit most from Lycium shawii supplementation based on its mechanisms?

Individuals seeking antioxidant support and those with metabolic concerns related to oxidative stress may benefit most from Lycium shawii, given its polyphenol content and traditional use for blood glucose management in Arabian medicine. People interested in plant-based antioxidants who tolerate herbal extracts well are good candidates, though those with existing diabetes should consult practitioners as the ingredient may modulate glucose levels. The herb's polyphenol profile suggests potential benefits for aging-related oxidative damage, though human clinical evidence remains limited.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*